Pleural Effusion
Welcome,         Profile    Billing    Logout  
 22 Companies   31 Products   31 Products   47 Mechanisms of Action   1 Trial   161 News 


«123»
  • ||||||||||  Avastin (bevacizumab) / Roche
    Trial primary completion date:  Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer (clinicaltrials.gov) -  Apr 14, 2015   
    P2,  N=30, Recruiting, 
    Trial primary completion date: Nov 2014 --> Nov 2015 Trial primary completion date: Jun 2015 --> Jun 2016
  • ||||||||||  pemetrexed / Generic mfg.
    Enrollment closed, Trial primary completion date:  Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer (clinicaltrials.gov) -  Mar 14, 2015   
    P2,  N=70, Active, not recruiting, 
    Recruiting --> Completed Completed --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Sep 2016
  • ||||||||||  Trial initiation date, Trial primary completion date:  Positive Airway Pressure on Pleural Effusion After Drainage (clinicaltrials.gov) -  Dec 12, 2014   
    P=N/A,  N=156, Not yet recruiting, 
    Not yet recruiting --> Recruiting Initiation date: Sep 2014 --> Dec 2014 | Trial primary completion date: Sep 2014 --> Dec 2014
  • ||||||||||  Trial primary completion date, Surgery:  Pleural and Pericardial Effusion Following Open Heart Surgery (clinicaltrials.gov) -  Nov 19, 2014   
    P=N/A,  N=150, Recruiting, 
    Initiation date: Sep 2014 --> Dec 2014 | Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Dec 2014 --> Jul 2015
  • ||||||||||  Avastin (bevacizumab) / Roche
    Trial primary completion date, Combination therapy, Metastases:  BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) (clinicaltrials.gov) -  Nov 11, 2014   
    P1,  N=60, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Nov 2014 Trial primary completion date: May 2015 --> May 2016
  • ||||||||||  Endostar (recombinant human endostatin) / Simcere
    Trial completion, Trial primary completion date, Pleural effusion:  Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites (clinicaltrials.gov) -  Aug 1, 2014   
    P2,  N=336, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Nov 2013 --> Apr 2014
  • ||||||||||  pemetrexed / Generic mfg.
    Trial completion, Trial primary completion date:  Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer (clinicaltrials.gov) -  Jul 23, 2014   
    P2,  N=64, Completed, 
    Recruiting --> Completed | Trial primary completion date: Nov 2013 --> Apr 2014 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2014
  • ||||||||||  Enrollment closed, Trial primary completion date, HEOR:  Pleural Catheters Versus Thoracoscopic Pleurodesis (clinicaltrials.gov) -  Jul 16, 2014   
    P=N/A,  N=445, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial primary completion date, Pleural effusion:  Malignant Pleural Effusion With ZD6474 (clinicaltrials.gov) -  Jun 24, 2014   
    P2,  N=28, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Oct 2015 --> Jun 2014
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial completion, Trial primary completion date, Pleural effusion:  Malignant Pleural Effusion With ZD6474 (clinicaltrials.gov) -  Jun 24, 2014   
    P2,  N=28, Completed, 
    N=12 --> 15 Active, not recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jun 2014
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Non-small Cell Lung Cancer Registry (clinicaltrials.gov) -  Feb 22, 2014   
    P4,  N=300, Completed, 
    Recruiting --> Completed No longer recruiting --> Completed